Adiponectin Level and Gene Variability Are Obesity and Metabolic Syndrome Markers in a Young Population

2000 Matsuzawa, 2006, The metabolic syndrome and adipocytokines, FEBS Lett, 580, 2917, 10.1016/j.febslet.2006.04.028 Grundy, 2005, Diagnosis and management of the MS: an American Heart Association/National Heart, Lung, and Blood Institute, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 Bralić, 2011, Growth and obesity in 7-year-old Croatian children: secular changes from 1991–2008, Eur J Pediatr, 10.1007/s00431-011-1470-1 Fišter, 2009, Increased body weight in Croatia, Coll Antropol, 33, 25 Yang, 2007, Genetic epidemiology of obesity, Epidemiol Rev, 29, 46, 10.1093/epirev/mxm004 Bell, 2005, The genetics of human obesity, Nat Rev Genet, 6, 221, 10.1038/nrg1556 Visvikis-Siest, 2008, The Stanislas Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases, Clin Chem Lab Med, 46, 733, 10.1515/CCLM.2008.178 Grundy, 2006, Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy, Nat Rev Drug Discov, 5, 295, 10.1038/nrd2005 Eckel, 2005, The metabolic syndrome: epidemiology, mechanisms, and therapy, Lancet, 365, 1415, 10.1016/S0140-6736(05)66378-7 Mantzoros, 2005, Circulating adiponectin levels are associated with better glycemic control, more favourable lipid profile, and reduced inflammation in women with type 2 diabetes, J Clin Endocrinol Metab, 90, 4542, 10.1210/jc.2005-0372 Gable, 2006, Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease, Atherosclerosis, 188, 231, 10.1016/j.atherosclerosis.2006.02.010 Kawano, 2009, The role of adiponectin in obesity, diabetes, and cardiovascular disease, J Cardiometab Syndr, 4, 44, 10.1111/j.1559-4572.2008.00030.x Okamoto, 2006, Adiponectin: a key adipocytokine in metabolic syndrome, Clin Sci, 110, 267, 10.1042/CS20050182 Heid, 2006, Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians, Diabetes, 55, 375, 10.2337/diabetes.55.02.06.db05-0747 Henneman, 2008, Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study, J Med Genet, 45, 572, 10.1136/jmg.2008.058388 Takahashi, 2000, Genomic structure and mutations in adipose-specific gene, adiponectin, Int J Obes Relat Metab Disord, 24, 861, 10.1038/sj.ijo.0801244 Henneman, 2010, Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits, Diabetes Care, 33, 908, 10.2337/dc09-1385 Kissebah, 2000, Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome, Proc Natl Acad Sci USA, 97, 14478, 10.1073/pnas.97.26.14478 Vasseur, 2002, Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians, Hum Mol Genet, 11, 2607, 10.1093/hmg/11.21.2607 Yang, 2006, Human genetics of adiponectin in the metabolic syndrome, J Mol Med, 84, 112, 10.1007/s00109-005-0011-7 World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation of Obesity; Geneva. Alberti, 1997, The metabolic syndrome—a new worldwide definition, Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8 1998 Friedwald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Blüher, 2007, Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays, Diabetes Care, 30, 280, 10.2337/dc06-1362 Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215 Schwarz, 2006, Hypoadiponectimia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter, Diabetes Care, 29, 1645, 10.2337/dc05-2123 Dudbridge, 2003, Pedigree disequilibrium tests for multilocus haplotypes, Genet Epidemiol, 25, 115, 10.1002/gepi.10252 Guo, 1992, Performing the exact test of Hardy-Weinberg proportions for multiple alleles, Biometrics, 48, 361, 10.2307/2532296 Excoffier, 2005, Arlequin (version 3.0): An Integrated Software Package for Population Genetics Data Analysis, Evol, Bioinform Online, 1, 47 Kolcic, 2010, Scale and dynamics of overweight and obesity epidemic in Croatia, Obes Facts, 3, 333, 10.1159/000321817 Guilherme, 2008, Adipocite dysfunctions linking obesity to insulin resistance and type 2 diabetes, Nat Rev, 9, 367, 10.1038/nrm2391 Povel, 2011, Genetic variants and the metabolic syndrome: a systematic review, Obes Rev, 12, 952, 10.1111/j.1467-789X.2011.00907.x Khunti, 2005, Metabolic syndrome, BMJ, 331, 1153, 10.1136/bmj.331.7526.1153 Siitonen, 2011, Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study, BMC Med Genet, 12, 5, 10.1186/1471-2350-12-5 Kishida, 2011, Visceral adiposity as a target for the management of the metabolic syndrome, Ann Med, 25 BenAli, 2011, Adiponectin and metabolic syndrome in a Tunisian population, Inflammation Ryo, 2004, Adiponectin as a biomarker of the metabolic syndrome, Circ J, 68, 975, 10.1253/circj.68.975 Rubin, 2008, The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise, Metabolism, 57, 683, 10.1016/j.metabol.2008.01.005 Yukihiro, 2002, Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population, Clin Sci, 103, 137, 10.1042/CS20010336 Kozłowska, 2006, The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease, Endokrynol Pol, 57, 626 Snehalatha, 2008, Plasma adiponectin does not correlate with insulin resistance and cardiometabolic variables in nondiabetic Asian Indian teenagers, Diabetes Care, 31, 2374, 10.2337/dc08-1083 Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat Med, 7, 941, 10.1038/90984 Huang, 2003, Plasma adiponectin levels and blood pressures in nondiabetic adolescent females, J Clin Endocrinol Metab, 88, 4130, 10.1210/jc.2003-030158 Adamczak, 2003, Decreased plasma adiponectin concentration in patients with essential hypertension, Am J Hyperten, 16, 72, 10.1016/S0895-7061(02)03197-7 Gong, 2010, Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis, Mol Cell Endocrinol, 325, 78, 10.1016/j.mce.2010.05.007 Park, 2011, ADIPOQ gene variants associated with susceptibility to obesity and low serum adiponectin levels in healthy Koreans, Epidemiol Health, 33, 1, 10.4178/epih/e2011003 Heid, 2010, Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals, Atherosclerosis, 208, 412, 10.1016/j.atherosclerosis.2009.11.035 Tanko, 2005, ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity, Obes Res, 13, 2113, 10.1038/oby.2005.262 Warodomwichit, 2009, ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study, Obesity, 17, 510, 10.1038/oby.2008.583 Vionnet, 2000, Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21–q24, Am J Hum Genet, 67, 1470, 10.1086/316887 Sutton, 2005, Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study, Hum Genet, 117, 107, 10.1007/s00439-005-1260-9 Petrone, 2006, The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity, Obesity, 14, 1498, 10.1038/oby.2006.172 Jang, 2008, The influence of the adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women, Clin Chim Acta, 391, 85, 10.1016/j.cca.2008.02.011 Jee, 2010, Adiponectin concentrations: a genome-wide association study, Am J Hum Genet, 87, 545, 10.1016/j.ajhg.2010.09.004 Ling, 2009, Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: The GEMS Study, Obesity, 17, 737, 10.1038/oby.2008.625 Moller, 2005, Metabolic syndrome: a clinical and molecular perspective, Annu Rev Med, 56, 45, 10.1146/annurev.med.56.082103.104751 Lara-Castro, 2006, Adiponectin multimeric complexes and the metabolic syndrome trait cluster, Diabetes, 55, 249, 10.2337/diabetes.55.01.06.db05-1105 Conneely, 2004, Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects, Diabetologia, 47, 1782, 10.1007/s00125-004-1537-x Cai, 2004, Principal component for metabolic syndrome risk maps to chromosome 4p in Mexican Americans: The San Antonio Family Heart Study, Hum Biol, 76, 10.1353/hub.2005.0001 McQueen, 2003, QTL genome scan of the metabolic syndrome and its component traits, BMC Genet, 4, S96, 10.1186/1471-2156-4-S1-S96 Arya, 2002, Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans, Diabetes, 51, 841, 10.2337/diabetes.51.3.841